DiaMedica Inc. Announces Public Offering
April 22, 2014 16:05 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - April 22, 2014) -
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
DiaMedica Inc. ("DiaMedica") (TSX...
DiaMedica Inc. to Amend the Expiry Date of Warrants
April 17, 2014 09:28 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - April 17, 2014) -
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
DiaMedica Inc....
DiaMedica to Present at the 2014 GTC Diabetes Summit
April 15, 2014 09:00 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - April 15, 2014) - DiaMedica Inc. (TSX VENTURE:DMA), a clinical stage biopharmaceutical company focused on the treatment of diabetes and its...
DiaMedica Appoints John Savage as Chief Financial Officer
April 07, 2014 09:07 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - April 7, 2014) - DiaMedica (TSX VENTURE:DMA) today announced the appointment of Mr. John Savage as the Company's Chief Financial Officer. Mr. Savage...
DiaMedica Files 20-F Registration Statement with U.S. SEC and Provides Clinical Update
February 19, 2014 08:30 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Feb. 19, 2014) - Minneapolis, Minnesota - DiaMedica (TSX VENTURE:DMA) announced that it has filed a Registration Statement on Form 20-F to register...
DiaMedica to Present at 16th Annual BIO CEO & Investor Conference
February 05, 2014 12:15 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Feb. 5, 2014) - DiaMedica (TSX VENTURE:DMA), a clinical stage biopharmaceutical company, announced today that Mr. Rick Pauls, Chief Executive...
DiaMedica Inc. Announces Partial Exercise of Over-Allotment Option
January 22, 2014 18:10 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Jan. 22, 2014) -
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
DiaMedica Inc....
DiaMedica Completes Phase 1 Clinical Trial and Initiates Phase 2 Clinical Trial of DM199 in Type 2 Diabetic Patients
January 09, 2014 08:30 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Jan. 9, 2014) - DiaMedica (TSX VENTURE:DMA), a clinical stage biopharmaceutical company announced today it has met the primary endpoints of safety...
DiaMedica Inc. Closes Non-Brokered Private Placement
January 03, 2014 10:44 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Jan. 3, 2014) -
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
DiaMedica Inc....
DiaMedica Inc. Announces Completion of $2.6 Million Prospectus Offering
December 23, 2013 09:26 ET
|
DiaMedica Inc.
MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 23, 2013) -
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
DiaMedica Inc....